The underlying conditions favoring or precipitating hepatic vein or inferior vena cava thrombosis must be recognized and treated. This essential part of therapy is beyond the scope of this review.

Several pathologic risk factors were identified, and later we reported that lack of endothelial strut coverage was the best single correlate of thrombosis. We also observed heterogeneity of ...

The antiphospholipid syndrome associated with hepatic vein thrombosis has usually been of the primary type; that is, the American Rheumatism Association criteria for the diagnosis of systemic ...